Suppr超能文献

相似文献

1
T cell circuits that sense antigen density with an ultrasensitive threshold.
Science. 2021 Mar 12;371(6534):1166-1171. doi: 10.1126/science.abc1855. Epub 2021 Feb 25.
2
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer.
Tumori. 2021 Aug;107(4):341-352. doi: 10.1177/0300891620960223. Epub 2020 Sep 28.
3
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.
Mol Ther. 2024 Aug 7;32(8):2741-2761. doi: 10.1016/j.ymthe.2024.06.023. Epub 2024 Jun 17.
4
[Specific cytotoxicity of a novel HER2-based chimeric antigen receptor modified T lymphocytes against HER2-positive tumor cells].
Zhonghua Bing Li Xue Za Zhi. 2017 Oct 8;46(10):714-720. doi: 10.3760/cma.j.issn.0529-5807.2017.10.011.
5
HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo.
Genes Immun. 2024 Jun;25(3):201-208. doi: 10.1038/s41435-024-00275-6. Epub 2024 May 3.
6
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
Clin Cancer Res. 2019 Jul 1;25(13):4014-4025. doi: 10.1158/1078-0432.CCR-18-2559. Epub 2019 Apr 12.
7
A Functional Screening Strategy for Engineering Chimeric Antigen Receptors with Reduced On-Target, Off-Tumor Activation.
Mol Ther. 2020 Dec 2;28(12):2564-2576. doi: 10.1016/j.ymthe.2020.08.003. Epub 2020 Aug 8.
10
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 Breast Cancer Metastasis to the Brain.
Clin Cancer Res. 2018 Jan 1;24(1):95-105. doi: 10.1158/1078-0432.CCR-17-2041. Epub 2017 Oct 23.

引用本文的文献

1
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.
J Immunother Cancer. 2025 Aug 25;13(8):e011761. doi: 10.1136/jitc-2025-011761.
2
Tracing the development of CAR-T cell design: from concept to next-generation platforms.
Front Immunol. 2025 Jul 17;16:1615212. doi: 10.3389/fimmu.2025.1615212. eCollection 2025.
3
4
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.
Signal Transduct Target Ther. 2025 Jul 9;10(1):213. doi: 10.1038/s41392-025-02299-4.
5
Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors.
Front Immunol. 2025 May 21;16:1514994. doi: 10.3389/fimmu.2025.1514994. eCollection 2025.
7
SynNotch CAR-T cell, when synthetic biology and immunology meet again.
Front Immunol. 2025 Apr 16;16:1545270. doi: 10.3389/fimmu.2025.1545270. eCollection 2025.
8
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy.
J Immunother Cancer. 2025 Apr 29;13(4):e010702. doi: 10.1136/jitc-2024-010702.
10
Post-transcriptional modular synthetic receptors.
Nat Chem Biol. 2025 Mar 28. doi: 10.1038/s41589-025-01872-w.

本文引用的文献

1
Human chimeric antigen receptor macrophages for cancer immunotherapy.
Nat Biotechnol. 2020 Aug;38(8):947-953. doi: 10.1038/s41587-020-0462-y. Epub 2020 Mar 23.
2
Cascaded amplifying circuits enable ultrasensitive cellular sensors for toxic metals.
Nat Chem Biol. 2019 May;15(5):540-548. doi: 10.1038/s41589-019-0244-3. Epub 2019 Mar 25.
3
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1.
4
TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves.
Oncoimmunology. 2018 Aug 1;7(9):e1462431. doi: 10.1080/2162402X.2018.1462431. eCollection 2018.
5
CAR-T cells: the long and winding road to solid tumors.
Cell Death Dis. 2018 Feb 15;9(3):282. doi: 10.1038/s41419-018-0278-6.
6
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med. 2018 Feb 1;378(5):439-448. doi: 10.1056/NEJMoa1709866.
7
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10.
8
Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers.
Clin Cancer Res. 2018 Mar 15;24(6):1277-1286. doi: 10.1158/1078-0432.CCR-17-0432. Epub 2017 Nov 14.
9
Chimeric antigen receptor T-cell therapies for lymphoma.
Nat Rev Clin Oncol. 2018 Jan;15(1):31-46. doi: 10.1038/nrclinonc.2017.128. Epub 2017 Aug 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验